The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Juvenile Diabetes Foundation Australia
80-84 Chandos Street
New South Wales, 2065
The Juvenile Diabetes Research Foundation Australia is a non-profit organization affiliated with the Juvenile Diabetes Research Foundation International in the United States. Established in 1982, the foundation is dedicated to funding basic and applied medical research to help discover a cure for diabetes and prevent its complications. Juvenile diabetes, also known as insulin-dependent diabetes or type I diabetes mellitus, is characterized by impaired carbohydrate, fat, and protein metabolism due to deficient production of insulin. This form of diabetes is an autoimmune disease in which insulin-secreting cells of the pancreas are destroyed due to an abnormal immune response. Associated symptoms have an abrupt onset and typically include excessive thirst and urination, weight loss and blurred vision. The Juvenile Diabetes Research Foundation Australia is committed to promoting and supporting scientific research; providing educational resources that are specific to the needs of children, young adults, and family members affected by juvenile diabetes; engaging in advocacy and lobbying efforts; and providing networking opportunities that enable those affected by juvenile diabetes to exchange information, resources, and mutual support.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.